The results indicated that AAV1‐based gene intervention was efficacious in PH and position pulmonary vascular KLF4 gene knockdown via intratracheal instillation as a preventive and therapeutic modality in CS‐PH. The gene discussed is KLF4; the disease is Cowden syndrome 1.